Endometrial cancer patients have high affinity antibodies for estrogen metabolite–receptor aggregate: A potential biomarker for EC
- 6 August 2020
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 46 (10) , 2115-2125
Abstract
Aim Elevated levels of 16 alpha-hydroxyestrone (16 alpha-OHE1) have been described in endometrial cancer (EC) and estrogen receptors (ER) expressed in endometrial tissue, but research on their combined role is lacking. We aimed to investigate the affinity and binding specificity of EC antibodies against the 16 alpha-OHE1-ER alpha aggregate in the serum of EC patients. Specificities of EC antibodies were also evaluated according to various clinical characteristics found in these cancer patients. Methods The binding specificity and affinity of EC antibodies against 16 alpha-OHE1-ER alpha in the serum of 120 EC patients were evaluated by direct binding and competition ELISA and quantitative precipitation titration. Binding of EC antibodies was also determined according to various clinical characteristics in EC patients through competition ELISA. Results Antibodies from EC patients demonstrated high recognition of 16 alpha-OHE1-ER alpha compared to ER alpha (P < 0.05) or 16 alpha-OHE1(P < 0.001). The relative affinity of EC IgG was 1.49 x 10(-7) M, 1.34 x 10(-6) M and 1.13 x 10(-6) M for 16 alpha-OHE1-ER alpha, ER alpha and 16 alpha-OHE1, respectively. Several factors, such as obesity, postmenopausal status, use of hormonal therapy, ER and progesterone receptor (PR) status, low 2-OHE1/16 alpha-OHE(1)ratio, chemotherapy and hypertension, augment the production of antibodies against 16 alpha-OHE1-ER alpha in EC patients. Conclusion 16 alpha-OHE1-ER alpha is a high-affinity antigen for EC antibodies in the serum of EC patients and might function as a biomarker for this disease. Furthermore, several factors enhanced the production of antibodies against 16 alpha-OHE1-ER alpha in the sera of these EC patients.Keywords
Funding Information
- Deanship of Scientific Research, King Saud University (R.G.P.1/53/39)
This publication has 37 references indexed in Scilit:
- Menopausal hormone therapy and risk of endometrial cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2014
- Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancerBritish Journal of Cancer, 2011
- Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancerInternational Journal of Cancer, 2010
- Life stress, negative mood states, and antibodies to heat shock protein 70 in endometrial cancerBrain, Behavior, and Immunity, 2010
- Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancerMolecular and Cellular Endocrinology, 2009
- Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)Endocrine-Related Cancer, 2008
- Self-Reported Stress and Risk of Endometrial Cancer: A Prospective Cohort StudyPsychosomatic Medicine, 2007
- Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancerJournal of Cancer Research and Clinical Oncology, 2004
- Increased estrogen-16α-hydroxylase activity in women with breast and endometrial cancerJournal of Steroid Biochemistry, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976